Views & Analysis | Perspectives on pharma industry issues

Skip to main content

Thursday 27 August 2026

BlueSky linkedin youtube

header links

Get Newsletters
Media Kit

Pharmaphorum menu first category

News
Views & Analysis
Deep Dive
Webinars
Podcasts
Videos
Spotlight on
Events

close

SECTION

News
Views & Analysis
Deep Dive
Webinars
Podcasts
Videos
White Papers
Events

Channels

Channels

Sales & Marketing
R&D
Digital
Market Access
Oncology
Patients
Spotlight On

Channels

Sales & Marketing
R&D
Digital
Market Access
Oncology
Patients
Spotlight On

SUB NAVIGATION

Live Coverage
Partner Content
About us
Work for us
Contribute
Contact us
Advertise

Newsletters and Deep Dive digital magazine

youtube linkedin BlueSky

Market Access

biotech investment graphic concept

Biotech funding has returned. The bar has moved with it.

For biotech sponsors, the question worth asking is not whether the rebound is real, but what it is actually rewarding.

Oncology

Cancer cell

Building a Phase I oncology centre

The question is not whether an institution should ultimately develop Phase Ia capability. It is when the organisation is ready.

Patients

Older couple high five each other on bicycles at top of hill

The strategic opportunity: Owning the behaviour layer

Behaviour is the layer that lifestyle, physical performance, and nutrition – together – occupy.

Sales & Marketing

BIO-Europe in Cologne, Germany

Media Partner

Why BIO-Europe 2026 matters: The evolution of strategic biop...

2026 marks a significant evolution for BIO-Europe.

Digital

HCP holds digital concept of AI drug discovery in palm of hand on black background

AI is redefining decision-making in biopharma R&D

AI has kickstarted a new wave of innovation in biopharma R&D.

Market Access

treetops with sunlight shining through

The benefits of ePI for patients and the planet

With one change made by one pharmaceutical company, we could save half a million trees every year. Imagine the impact if the change was made across industry.

R&D

LSX World Congress – Day 1 banner

LSX World Congress – Day One

Day One will kick off with a couple of sessions on the investing landscape, including one featuring speakers from Google and Eli Lilly.

R&D

LSX World Congress banner

LSX World Congress – Live coverage

At the LSX (Life Sciences Executive) World Congress in Boston, leaders in biotech, healthtech, and medtech will gather to share trends, insights, and strategies for keeping on top of the va

Load more results

Sales & Marketing

Sales & Marketing

BIO-Europe in Cologne, Germany

Media Partner

Why BIO-Europe 2026 matters: The evolution of strategic biop...

2026 marks a significant evolution for BIO-Europe.

Sales & Marketing

Recruitment concept graphic on beige background

Changing Faces: Agency, consultancy, and investor hires, Jun...

Agencies, consultancies, investment groups, and wider services firms saw significant talent movement across June and July.

Digital

Digital

HCP holds digital concept of AI drug discovery in palm of hand on black background

AI is redefining decision-making in biopharma R&D

AI has kickstarted a new wave of innovation in biopharma R&D.

Digital

Technology solutions for smarter clinical trials: Inventus

Sponsored

Technology solutions for smarter clinical trials: Inventus

In an exclusive video interview, Steve Sanghera – CEO and co-founder of Inventus – sat down with pharmaphorum to discuss the company's journey & ethos

Market Access

Market Access

biotech investment graphic concept

Biotech funding has returned. The bar has moved with it.

For biotech sponsors, the question worth asking is not whether the rebound is real, but what it is actually rewarding.

Market Access

Mumbai, India

What India can learn from Kinvard Bio

India needs its own version of pull, designed for an Indian payer mix, an Indian procurement structure, and an Indian distributor network.

Editor's Picks

MSD, Moderna skin cancer vaccine scores historic phase 3 win

Trump taps White House aide Heidi Overton to lead FDA

Sandoz adds 10 biosimilars through $322m Henlius deal

Claude Science outperforms experts in protein binder task

Sanofi to lay off 229 Blueprint employees, close offices

Newsletters and Deep Dive
digital magazine

Get Newsletters

Get in-depth news, opinions, and features on pharma and healthcare sent straight to your inbox

Oncology

Oncology

Cancer cell

Building a Phase I oncology centre

The question is not whether an institution should ultimately develop Phase Ia capability. It is when the organisation is ready.

Oncology

leukaemia

Key lessons from EHA 2026: Translating evidence into impact

Across four days in Sweden, EHA 2026 offered a clear view of the future of blood cancer care.

Oncology

Solid tumour spreading

Sponsored

Establishing ctDNA as a validated primary surrogate endpoint

Circulating tumour DNA (ctDNA) has emerged as a promising primary surrogate endpoint in solid tumour oncology.

Patients

Patients

Older couple high five each other on bicycles at top of hill

The strategic opportunity: Owning the behaviour layer

Behaviour is the layer that lifestyle, physical performance, and nutrition – together – occupy.

Patients

pharmaphorum podcast Episode 273, James Davis, PA Consulting

Deliver prevention at scale, PA Consulting’s James Davis

James Davis, a healthcare expert at PA Consulting, discusses the digital foundations needed to unlock a prevention first NHS.

Patients

Two faced man's silhouette, one side blue, the other red, with faces in the background

In schizophrenia care, even the support system needs support

After a schizophrenia diagnosis, families must learn how to navigate treatment, respond to symptoms, and communicate effectively.

R&D

R&D

two healthcare professionals looking at chart

Sponsored

Decentralisation by design: Bringing the trial closer withou...

In the third episode of the IQVIA-sponsored PSCS leadership video series, Sinead Callinan, Head of Patient Centred Delivery, discusses DCTs.

R&D

Board of Directors graphic over sunset across cityscape

Changing Faces: Board appointments, June and July 2026

Board appointments June/July brought together veterans from across the pharmaceutical industry, venture capital, healthcare technology, and academia

R&D

Empty waiting room chairs for clinical trial enrolment

When metrics measure more than they improve

The question to ask is not, "Are we measuring site performance?" but, "Are the metrics we collect providing actionable insights early enough?"

Editor's Picks

MSD, Moderna skin cancer vaccine scores historic phase 3 win

Trump taps White House aide Heidi Overton to lead FDA

Sandoz adds 10 biosimilars through $322m Henlius deal

Claude Science outperforms experts in protein binder task

Sanofi to lay off 229 Blueprint employees, close offices

News

Sword Health buys Headspace in $200M to $300M deal

Digital mental health company Headspace will be acquired by Sword Health next month, according to regulatory filings.

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png

Digital

Discover a new era of healthcare panel engagement

Sponsored

Discover a new era of healthcare panel engagement: Grounded ...

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.

Pharmaphorum Menu

Digital
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Market Access
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Oncology
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Patients
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
R&D
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Sales & Marketing
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Spotlight on

Sign up for email newsletters and Deep Dive

Get Newsletters

youtube linkedin BlueSky

About us Advertising Contact us

Contribute Cookie Policy Privacy Policy

Terms & Conditions Work for us

The rights of trademark owners are acknowledged. Website and content copyright © 2009-2026, pharmaphorum media limited or its licensors; all rights reserved. pharmaphorum – an EVERSANA company

The rights of trademark owners are acknowledged. Website and content copyright © 2009-2026, pharmaphorum media limited or its licensors; all rights reserved. pharmaphorum – an EVERSANA company